Testing revealed that the amount of NDMA in a batch of 750 mg Metformin HCl Extended-Release Tablets from Nostrum Laboratories was higher than the accepted maximum, and thus a recall was issued.

In a new recall bulletin posted by the FDA, Nostrum Laboratories, Inc., is recalling one lot of a popular type 2 diabetes medication. The company’s generic Metformin HCl Extended-Release Tablets ...

CA), 1,500 mg extended-release metformin twice daily (500 mg in the morning and 1,000 mg in the evening), 2,000 mg extended-release metformin q.d., or 1,500 mg immediate-release metformin twice ...